留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma

Yongyang Bao J. Eva Selfridge Janet Wang Yiqing Zhao Junqi Cui Kishore Guda Zhenghe Wang Yanbo Zhu

Yongyang Bao, J. Eva Selfridge, Janet Wang, Yiqing Zhao, Junqi Cui, Kishore Guda, Zhenghe Wang, Yanbo Zhu. Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma[J]. Journal of Genetics and Genomics, 2019, 46(6): 315-318. doi: 10.1016/j.jgg.2019.06.001
Citation: Yongyang Bao, J. Eva Selfridge, Janet Wang, Yiqing Zhao, Junqi Cui, Kishore Guda, Zhenghe Wang, Yanbo Zhu. Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma[J]. Journal of Genetics and Genomics, 2019, 46(6): 315-318. doi: 10.1016/j.jgg.2019.06.001

doi: 10.1016/j.jgg.2019.06.001

Mutations in TP53, ZNF750, and RB1 typify ocular sebaceous carcinoma

More Information
  • These authors contributed equally to this work.
  • [1] Boxer, L.D., Barajas, B., Tao, S., Zhang, J., and Khavari, P.A. (2014). ZNF750 interacts with KLF4 and RCOR1, KDM1A, and CTBP1/2 chromatin regulators to repress epidermal progenitor genes and induce differentiation genes. Genes Dev. 28, 2013-2026.
    [2] Cohen, I., Birnbaum, R.Y., Leibson, K., Taube, R., Sivan, S., and Birk, O.S. (2012). ZNF750 is expressed in differentiated keratinocytes and regulates epidermal late differentiation genes. PloS One 7, e42628.
    [3] Dai, W., Ko, J.M.Y., Choi, S.S.A., Yu, Z., Ning, L., Zheng, H., Gopalan, V., Chan, K.T., Lee, N.P., Chan, K.W., Law, S.Y., Lam, A.K., and Lung, M.L. (2017). Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma. J Pathol. 242, 500-510.
    [4] Deprez, M., and Uffer, S. (2009). Clinicopathological features of eyelid skin tumors. A retrospective study of 5504 cases and review of literature. Am. J. Dermatopathol. 31, 256-262.
    [5] do Valle, I.F., Giampieri, E., Simonetti, G., Padella, A., Manfrini, M., Ferrari, A., Papayannidis, C., Zironi, I., Garonzi, M., Bernardi, S., Delledonne, M., Martinelli, G., Remondini, D., and Castellani, G. (2016). Optimized pipeline of MuTect and GATK tools to improve the detection of somatic single nucleotide polymorphisms in whole-exome sequencing data. BMC Bioinformatics 17, 341.
    [6] Guo, T., Gaykalova, D.A., Considine, M., Wheelan, S., Pallavajjala, A., Bishop, J.A., Westra, W.H., Ideker, T., Koch, W.M., Khan, Z., Fertig, E.J., and Califano, J.A. (2016). Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma. Int. J. Cancer. 139, 373-382.
    [7] Harvey, N.T., Tabone, T., Erber, W., and Wood, B.A. (2016). Circumscribed sebaceous neoplasms: a morphological, immunohistochemical and molecular analysis. Pathology 48, 454-462.
    [8] Hazawa, M., Lin, D.C., Handral, H., Xu, L., Chen, Y., Jiang, Y.Y., Mayakonda, A., Ding, L.W., Meng, X., Sharma, A., Samuel, S., Movahednia, M.M., Wong, R.W., Yang, H., Tong, C., and Koeffler, H.P. (2017). ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma. Oncogene 36, 2243-2254.
    [9] Hussain, R.M., Matthews, J.L., Dubovy, S.R., Thompson, J.M., and Wang, G. (2014). UV-independent p53 mutations in sebaceous carcinoma of the eyelid. Ophthalmic Plast. Reconstr. Surg. 30, 392-395.
    [10] Kiyosaki, K., Nakada, C., Hijiya, N., Tsukamoto, Y., Matsuura, K., Nakatsuka, K., Daa, T., Yokoyama, S., Imaizumi, M., and Moriyama, M. (2010). Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid. Invest. Ophthalmol. Vis. Sci. 51, 7-11.
    [11] Koboldt, D.C., Zhang, Q., Larson, D.E., Shen, D., McLellan, M.D., Lin, L., Miller, C.A., Mardis, E.R., Ding, L., and Wilson, R.K. (2012). VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568-576.
    [12] Muqit, M.M., Foot, B., Walters, S.J., Mudhar, H.S., Roberts, F., and Rennie, I.G. (2013). Observational prospective cohort study of patients with newly-diagnosed ocular sebaceous carcinoma. Br. J. Ophthalmol. 97, 47-51.
    [13] North, J.P., Golovato, J., Vaske, C.J., Sanborn, J.Z., Nguyen, A., Wu, W., Goode, B., Stevers, M., McMullen, K., Perez White, B.E., Collisson, E.A., Bloomer, M., Solomon, D.A., Benz, S.C., and Cho, R.J. (2018). Cell of origin and mutation pattern define three clinically distinct classes of sebaceous carcinoma. Nat. Commun. 9, 1894.
    [14] Otsuka, R., Akutsu, Y., Sakata, H., Hanari, N., Murakami, K., Kano, M., Takahashi, M., Matsumoto, Y., Sekino, N., Yokoyama, M., Iida, K., and Matsubara, H. (2017). ZNF750 expression as a novel candidate biomarker of chemoradiosensitivity in esophageal squamous cell carcinoma. Oncology 93, 197-203.
    [15] Otsuka, R., Akutsu, Y., Sakata, H., Hanari, N., Murakami, K., Kano, M., Toyozumi, T., Takahashi, M., Matsumoto, Y., Sekino, N., Yokoyama, M., Okada, K., Shiraishi, T., Komatsu, A., Iida, K., and Matsubara, H. (2018). ZNF750 expression is a potential prognostic biomarker in esophageal squamous cell carcinoma. Oncology 94, 142-148.
    [16] Pan, L., Yang, H., Xu, C., Chen, S., Meng, Z., Li, K., and Chen, H. (2018). ZNF750 inhibited the malignant progression of oral squamous cell carcinoma by regulating tumor vascular microenvironment. Biomed. Pharmacother. 105, 566-572.
    [17] Sen, G.L., Boxer, L.D., Webster, D.E., Bussat, R.T., Qu, K., Zarnegar, B.J., Johnston, D., Siprashvili, Z., and Khavari, P.A. (2012). ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation. Dev. Cell 22, 669-677.
    [18] Shields, J.A., Demirci, H., Marr, B.P., Eagle, R.C., Jr., and Shields, C.L. (2004). Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology 111, 2151-2157.
    [19] Sun, B.K., Boxer, L.D., Ransohoff, J.D., Siprashvili, Z., Qu, K., Lopez-Pajares, V., Hollmig, S.T., and Khavari, P.A. (2015). CALML5 is a ZNF750- and TINCR-induced protein that binds stratifin to regulate epidermal differentiation. Genes Dev. 29, 2225-2230.
    [20] Tetzlaff, M.T., Singh, R.R., Seviour, E.G., Curry, J.L., Hudgens, C.W., Bell, D., Wimmer, D.A., Ning, J., Czerniak, B.A., Zhang, L., Davies, M.A., Prieto, V.G., Broaddus, R.R., Ram, P., Luthra, R., and Esmaeli, B. (2016). Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J. Pathol. 240, 84-95.
    [21] Tetzlaff, M.T., Curry, J.L., Ning, J., Sagiv, O., Kandl, T.L., Peng, B., Bell, D., Routbort, M., Hudgens, C.W., Ivan, D., Kim, T.B., Chen, K., Eterovic, A.K., Shaw, K., Prieto, V.G., Yemelyanova, A., and Esmaeli, B. (2019). Distinct biological types of ocular adnexal sebaceous carcinoma: HPV-driven and virus-negative tumors arise through nonoverlapping molecular-genetic alterations. Clin. Cancer Res. 25, 1280-1290.
    [22] Xu, Y., Li, F., Jia, R., and Fan, X. (2018). Updates on the clinical diagnosis and management of ocular sebaceous carcinoma: a brief review of the literature. Onco. Targets Ther. 11, 3713-3720.
    [23] Yang, H., Pan, L., Xu, C., Zhang, Y., Li, K., Chen, S., Zhang, B., Liu, Z., Wang, L.X., and Chen, H. (2017). Overexpression of tumor suppressor gene ZNF750 inhibits oral squamous cell carcinoma metastasis. Oncol. Lett. 14, 5591-5596.
    [24] Yu, S.S., Zhao, Y., Zhao, H., Lin, J.Y., and Tang, X. (2018). A retrospective study of 2228 cases with eyelid tumors. Int. J. Ophthalmol. 11, 1835-1841.
    [25] Zurcher, M., Hintschich, C.R., Garner, A., Bunce, C., and Collin, J.R. (1998). Sebaceous carcinoma of the eyelid: a clinicopathological study. Br. J. Ophthalmol. 82, 1049-1055.
  • 加载中
计量
  • 文章访问数:  87
  • HTML全文浏览量:  44
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2019-04-06
  • 录用日期:  2019-06-14
  • 修回日期:  2019-05-23
  • 网络出版日期:  2019-06-21
  • 刊出日期:  2019-06-20

目录

    /

    返回文章
    返回